Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: corticosteroids

Improved Family Planning Counseling Needed

Susan Bernstein  |  May 18, 2018

In the U.S. today, approximately 45% of pregnancies are unintended or unplanned.1 Although this rate is considerably lower than in the past, women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or inflammatory myopathies tend to have better pregnancy outcomes if their disease is well controlled when they conceive. In addition, women taking certain medications…

Filed under:Conditions Tagged with:contraceptivecounselingpregnancy

Exciting Advances in Giant Cell Arteritis Diagnosis & Treatment

Jason Liebowitz, MD, FACR  |  May 17, 2018

Baltimore—Rheumatologists and meteor­ologists share more in common than you might suspect, said Dr. Rebecca Manno, assistant professor of medicine for the Division of Rheumatology at Johns Hopkins University, Baltimore, and assistant director of the Johns Hopkins Vasculitis Center. At a March 8 meeting of the Maryland Society for the Rheumatic Diseases, Dr. Manno used the…

Filed under:Vasculitis Tagged with:Giant Cell Arteritistocilizumab

Should You Treat SSc with Cyclophosphamide or Mycophenolate?

Lara C. Pullen, PhD  |  May 17, 2018

Patients with scleroderma, systemic sclerosis (SSc), myositis and rheuma­toid arthritis (RA) may develop interstitial lung disease (ILD), which affects a patient’s breathing and quality of life. Prospective studies have revealed that in patients with SSc a greater rate of decline of forced vital capacity (FVC) is associated with increased mortality. Although corticosteroids are commonly used…

Filed under:Systemic Sclerosis Tagged with:cyclophosphamideMycophenolateSScSystemic sclerosis

New Study Examines Treatment Options for Incomplete Lupus Erythematous

Catherine Kolonko  |  April 26, 2018

A recent study explored medical concerns for patients who have lupus markers, but fall short of meeting enough criteria for official disease classification. Investigators at the Oklahoma Medical Research Foundation conducted a large study to explore current treatments of patients with incomplete lupus erythematous (ILE) and to compare antibody characteristics to healthy people and patients…

Filed under:Systemic Lupus Erythematosus Tagged with:Incomplete Lupus ErythematousLupusSLEsystemic lupus erythematous

Using Ultrasound to Diagnose Carpal Tunnel Syndrome

Mark H. Greenberg, MD, RMSK, RhMSUS, Julian Greer, & James W. Fant Jr., MD  |  April 26, 2018

Note: Updated May 2, 2018, to correct a link in the reference section. The error was introduced in editing. A 44-year-old Caucasian woman presented to the outpatient rheumatology clinic that had followed her for several years for rheumatoid arthritis. She was compliant with her regimen of hydroxychloroquine, etanercept and salsalate. Her chief complaint was worsening…

Filed under:ConditionsSoft Tissue Pain Tagged with:Carpal Tunnel Syndromecase reportelectrophysiological studiesUltrasound

Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease

Lara C. Pullen, PhD  |  April 9, 2018

A recent systematic review found no clear evidence that rheumatoid arthritis patients treated with cyclophosphamide have better lung function than those treated with mycophenolate mofetil. The researchers caution that physicians should expect treatment with cyclophosphamide may only result in a modest improvement in the preservation of forced vital capacity…

Filed under:ConditionsRheumatoid Arthritis Tagged with:cyclophosphamideInterstitial Lung Diseaselunglung diseaselungsrespiratory

The Link Between Takayasu’s Arteritis & Increased Stroke Risk

Lara C. Pullen, PhD  |  March 26, 2018

Approximately 16% of patients diagnosed with Takayasu’s arteritis (TA) experience a stroke. In a recent study, researchers found patients with TA and stroke had higher levels of C-reactive protein at diagnosis…

Filed under:Conditions Tagged with:brainstrokeTakayasu’s Arteritis

Ethics Forum: What to Do When an Autoimmune Patient Needs a Transplant?

W. Blaine Lapin, MD, Jennifer L. Rammel, MD, MPH, & Andrea A. Ramirez, MD, MEd  |  March 19, 2018

Despite our best efforts and modern interventions, we still have patients in the intensive care unit with organ failure. Although renal failure can be mitigated by dialysis, patients with cardiac or respiratory failure secondary to active autoimmune disease raise difficult clinical and ethical issues. Two recent cases, both with organ failure, led us to examine…

Filed under:ConditionsEthics Tagged with:transplantation

Updates on Managing Lupus Complications

Susan Bernstein  |  March 17, 2018

SAN DIEGO—To manage patients with systemic lupus erythematous (SLE), rheuma­tologists must be aware of potentially serious complications affecting many organ systems. On Nov. 7 at the 2017 ACR/ARHP Annual Meeting, two experts offered insights on cardiovascular and hematological complications of lupus. Myocardial Disease in Lupus Lupus patients are at increased risk for heart-related complications, especially…

Filed under:Meeting ReportsSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetinganemiaCoombshemolysisLupusmyocardial inflammationSLEsplenectomy

Dealing with Simultaneous Cancer & Rheumatic Disease

Thomas R. Collins  |  March 17, 2018

SAN DIEGO—New insights into how scleroderma and myositis may be linked with cancer have led to intriguing questions that could impact patient care, experts said at the 2017 ACR/ARHP Annual Meeting in November. Understanding the relationship between cancer and rheumatic diseases is important because rheumatologists are seeing more and more patients with both diseases, and…

Filed under:Meeting ReportsSystemic Sclerosis Tagged with:ACR/ARHP Annual Meeting

  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 44
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences